Global PROTAC Technology 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR082413760

Publication Date:

August 22, 2024

Pages:

122

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Software [2]

IT Services [3]

Computing & Electronics [4]

Description:

The global PROTAC Technology market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
As a new type of small molecule drug development technology, PROTAC is receiving more and more attention. Major pharmaceutical companies and biotechnology companies have invested heavily in research and development in the hope of making breakthroughs in this field. With the continuous advancement of technology and the accumulation of clinical data, PROTAC is expected to achieve more breakthroughs in the next few years and provide more possibilities for the development of new drugs.
This report is a detailed and comprehensive analysis for global PROTAC Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global PROTAC Technology market size and forecasts, in consumption value ($ Million), 2019-2030
Global PROTAC Technology market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global PROTAC Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global PROTAC Technology market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PROTAC Technology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PROTAC Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Arvinas, Captor therapeutics, Pfizer, Amgen, Oerth Bio, Bayer, Kymera, Nurix, C4 Therapeutics, Inc., Astellas Pharma Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
PROTAC Technology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segmentation
PROTAC Technology market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Based on CRBN
Based on VHL
麻豆原创 segment by Application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Pancreatic Cancer
Lymphoma
Androgenic Alopecia
Others
麻豆原创 segment by players, this report covers
Arvinas
Captor therapeutics
Pfizer
Amgen
Oerth Bio
Bayer
Kymera
Nurix
C4 Therapeutics, Inc.
Astellas Pharma Inc.
AbbVie
Kaituo Pharmaceutical
Betta Pharmaceuticals
Hengrui Medicine
BeiGene
Haichuang Pharmaceutical
East China Pharmaceutical Group
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe PROTAC Technology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of PROTAC Technology, with revenue, gross margin, and global market share of PROTAC Technology from 2019 to 2024.
Chapter 3, the PROTAC Technology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and PROTAC Technology market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of PROTAC Technology.
Chapter 13, to describe PROTAC Technology research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of PROTAC Technology by Type
1.3.1 Overview: Global PROTAC Technology 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global PROTAC Technology Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Based on CRBN
1.3.4 Based on VHL
1.4 Global PROTAC Technology 麻豆原创 by Application
1.4.1 Overview: Global PROTAC Technology 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Breast Cancer
1.4.3 Prostate Cancer
1.4.4 Colorectal Cancer
1.4.5 Pancreatic Cancer
1.4.6 Lymphoma
1.4.7 Androgenic Alopecia
1.4.8 Others
1.5 Global PROTAC Technology 麻豆原创 Size & Forecast
1.6 Global PROTAC Technology 麻豆原创 Size and Forecast by Region
1.6.1 Global PROTAC Technology 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global PROTAC Technology 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America PROTAC Technology 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe PROTAC Technology 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific PROTAC Technology 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America PROTAC Technology 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East & Africa PROTAC Technology 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Arvinas
2.1.1 Arvinas Details
2.1.2 Arvinas Major Business
2.1.3 Arvinas PROTAC Technology Product and Solutions
2.1.4 Arvinas PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Arvinas Recent Developments and Future Plans
2.2 Captor therapeutics
2.2.1 Captor therapeutics Details
2.2.2 Captor therapeutics Major Business
2.2.3 Captor therapeutics PROTAC Technology Product and Solutions
2.2.4 Captor therapeutics PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Captor therapeutics Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer PROTAC Technology Product and Solutions
2.3.4 Pfizer PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen PROTAC Technology Product and Solutions
2.4.4 Amgen PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Amgen Recent Developments and Future Plans
2.5 Oerth Bio
2.5.1 Oerth Bio Details
2.5.2 Oerth Bio Major Business
2.5.3 Oerth Bio PROTAC Technology Product and Solutions
2.5.4 Oerth Bio PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Oerth Bio Recent Developments and Future Plans
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer PROTAC Technology Product and Solutions
2.6.4 Bayer PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Bayer Recent Developments and Future Plans
2.7 Kymera
2.7.1 Kymera Details
2.7.2 Kymera Major Business
2.7.3 Kymera PROTAC Technology Product and Solutions
2.7.4 Kymera PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Kymera Recent Developments and Future Plans
2.8 Nurix
2.8.1 Nurix Details
2.8.2 Nurix Major Business
2.8.3 Nurix PROTAC Technology Product and Solutions
2.8.4 Nurix PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Nurix Recent Developments and Future Plans
2.9 C4 Therapeutics, Inc.
2.9.1 C4 Therapeutics, Inc. Details
2.9.2 C4 Therapeutics, Inc. Major Business
2.9.3 C4 Therapeutics, Inc. PROTAC Technology Product and Solutions
2.9.4 C4 Therapeutics, Inc. PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 C4 Therapeutics, Inc. Recent Developments and Future Plans
2.10 Astellas Pharma Inc.
2.10.1 Astellas Pharma Inc. Details
2.10.2 Astellas Pharma Inc. Major Business
2.10.3 Astellas Pharma Inc. PROTAC Technology Product and Solutions
2.10.4 Astellas Pharma Inc. PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Astellas Pharma Inc. Recent Developments and Future Plans
2.11 AbbVie
2.11.1 AbbVie Details
2.11.2 AbbVie Major Business
2.11.3 AbbVie PROTAC Technology Product and Solutions
2.11.4 AbbVie PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 AbbVie Recent Developments and Future Plans
2.12 Kaituo Pharmaceutical
2.12.1 Kaituo Pharmaceutical Details
2.12.2 Kaituo Pharmaceutical Major Business
2.12.3 Kaituo Pharmaceutical PROTAC Technology Product and Solutions
2.12.4 Kaituo Pharmaceutical PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Kaituo Pharmaceutical Recent Developments and Future Plans
2.13 Betta Pharmaceuticals
2.13.1 Betta Pharmaceuticals Details
2.13.2 Betta Pharmaceuticals Major Business
2.13.3 Betta Pharmaceuticals PROTAC Technology Product and Solutions
2.13.4 Betta Pharmaceuticals PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Betta Pharmaceuticals Recent Developments and Future Plans
2.14 Hengrui Medicine
2.14.1 Hengrui Medicine Details
2.14.2 Hengrui Medicine Major Business
2.14.3 Hengrui Medicine PROTAC Technology Product and Solutions
2.14.4 Hengrui Medicine PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Hengrui Medicine Recent Developments and Future Plans
2.15 BeiGene
2.15.1 BeiGene Details
2.15.2 BeiGene Major Business
2.15.3 BeiGene PROTAC Technology Product and Solutions
2.15.4 BeiGene PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 BeiGene Recent Developments and Future Plans
2.16 Haichuang Pharmaceutical
2.16.1 Haichuang Pharmaceutical Details
2.16.2 Haichuang Pharmaceutical Major Business
2.16.3 Haichuang Pharmaceutical PROTAC Technology Product and Solutions
2.16.4 Haichuang Pharmaceutical PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 Haichuang Pharmaceutical Recent Developments and Future Plans
2.17 East China Pharmaceutical Group
2.17.1 East China Pharmaceutical Group Details
2.17.2 East China Pharmaceutical Group Major Business
2.17.3 East China Pharmaceutical Group PROTAC Technology Product and Solutions
2.17.4 East China Pharmaceutical Group PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 East China Pharmaceutical Group Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global PROTAC Technology Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of PROTAC Technology by Company Revenue
3.2.2 Top 3 PROTAC Technology Players 麻豆原创 Share in 2023
3.2.3 Top 6 PROTAC Technology Players 麻豆原创 Share in 2023
3.3 PROTAC Technology 麻豆原创: Overall Company Footprint Analysis
3.3.1 PROTAC Technology 麻豆原创: Region Footprint
3.3.2 PROTAC Technology 麻豆原创: Company Product Type Footprint
3.3.3 PROTAC Technology 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global PROTAC Technology Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global PROTAC Technology 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global PROTAC Technology Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global PROTAC Technology 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America PROTAC Technology Consumption Value by Type (2019-2030)
6.2 North America PROTAC Technology 麻豆原创 Size by Application (2019-2030)
6.3 North America PROTAC Technology 麻豆原创 Size by Country
6.3.1 North America PROTAC Technology Consumption Value by Country (2019-2030)
6.3.2 United States PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe PROTAC Technology Consumption Value by Type (2019-2030)
7.2 Europe PROTAC Technology Consumption Value by Application (2019-2030)
7.3 Europe PROTAC Technology 麻豆原创 Size by Country
7.3.1 Europe PROTAC Technology Consumption Value by Country (2019-2030)
7.3.2 Germany PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific PROTAC Technology Consumption Value by Type (2019-2030)
8.2 Asia-Pacific PROTAC Technology Consumption Value by Application (2019-2030)
8.3 Asia-Pacific PROTAC Technology 麻豆原创 Size by Region
8.3.1 Asia-Pacific PROTAC Technology Consumption Value by Region (2019-2030)
8.3.2 China PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America PROTAC Technology Consumption Value by Type (2019-2030)
9.2 South America PROTAC Technology Consumption Value by Application (2019-2030)
9.3 South America PROTAC Technology 麻豆原创 Size by Country
9.3.1 South America PROTAC Technology Consumption Value by Country (2019-2030)
9.3.2 Brazil PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa PROTAC Technology Consumption Value by Type (2019-2030)
10.2 Middle East & Africa PROTAC Technology Consumption Value by Application (2019-2030)
10.3 Middle East & Africa PROTAC Technology 麻豆原创 Size by Country
10.3.1 Middle East & Africa PROTAC Technology Consumption Value by Country (2019-2030)
10.3.2 Turkey PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE PROTAC Technology 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 PROTAC Technology 麻豆原创 Drivers
11.2 PROTAC Technology 麻豆原创 Restraints
11.3 PROTAC Technology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 PROTAC Technology Industry Chain
12.2 PROTAC Technology Upstream Analysis
12.3 PROTAC Technology Midstream Analysis
12.4 PROTAC Technology Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Arvinas
Captor therapeutics
Pfizer
Amgen
Oerth Bio
Bayer
Kymera
Nurix
C4 Therapeutics, Inc.
Astellas Pharma Inc.
AbbVie
Kaituo Pharmaceutical
Betta Pharmaceuticals
Hengrui Medicine
BeiGene
Haichuang Pharmaceutical
East China Pharmaceutical Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.